Pharmaceutics (Aug 2022)

Host Response Modulation Therapy in the Diabetes Mellitus—Periodontitis Conjuncture: A Narrative Review

  • Irina-Georgeta Sufaru,
  • Silvia Teslaru,
  • Liliana Pasarin,
  • Gianina Iovan,
  • Simona Stoleriu,
  • Sorina Mihaela Solomon

DOI
https://doi.org/10.3390/pharmaceutics14081728
Journal volume & issue
Vol. 14, no. 8
p. 1728

Abstract

Read online

The inflammatory response of the host in periodontitis is the phenomenon that underlies the onset and evolution of periodontal destructive phenomena. A number of systemic factors, such as diabetes mellitus (DM), can negatively affect the patient with periodontitis, just as the periodontal disease can aggravate the status of the DM patient. Host response modulation therapy involves the use of anti-inflammatory and anti-oxidant products aimed at resolving inflammation, stopping destructive processes, and promoting periodontal healing, all important aspects in patients with high tissue loss rates, such as diabetic patients. This paper reviews the data available in the literature on the relationship between DM and periodontitis, the main substances modulating the inflammatory response (nonsteroidal anti-inflammatory drugs, sub-antimicrobial doses of doxycycline, or omega-3 fatty acids and their products, specialized pro-resolving mediators), as well as their application in diabetic patients.

Keywords